With such great potential for this technology, there come some daunting ethical concerns, and the scientific community is aware of and continually monitoring these, much like when cloning and stem cell research were first introduced. This technology may bring about a treatment for the most debilitating disorders, but could commercialization lead to the creation of designer-perfect babies? Who can define the line between what is considered normal versus a disability? As a preventative therapy, how do we determine what population is offered this opportunity? What role will the medical and legal systems play in determining the ethical monitoring of this powerful technology?
Truly, it’s a brave new world.
Ad Statistics
Times Displayed: 64502
Times Visited: 2110 Ampronix, a Top Master Distributor for Sony Medical, provides Sales, Service & Exchanges for Sony Surgical Displays, Printers, & More. Rely on Us for Expert Support Tailored to Your Needs. Email info@ampronix.com or Call 949-273-8000 for Premier Pricing.
About the Author: Diana Trinh joined MD Buyline in April 2017 as a clinical analyst specializing in laboratory and pharmacy. She brought more than eight years of experience in medical laboratory science in several multi-disciplines, including microbiology, bone marrow biopsies, special coagulation, and flow cytometry at Parkland Health and Hospital System in Dallas. In addition, she served as a histocompatibility technologist in the ASHI-accredited Immunogenomics and Transplantation laboratory at Baylor University Medical Center in Dallas, North Texas’s largest transplant center. She also brings with her research laboratory experience in molecular and structural biology from UT Health San Antonio.
Trinh received her Bachelor of Science degree in Clinical Laboratory Science from UT Health San Antonio, and previously studied biology at Trinity University and at UT in San Antonio. She is a member of the American Society of Clinical Pathology and obtained her MLS(ASCP)CM certification in 2009.Back to HCB News
